Results 61 to 70 of about 75,785 (221)

Fertility and pregnancy outcomes following conservative treatment for placenta accreta.: Fertility after placenta accreta [PDF]

, 2010
International audienceBACKGROUND: The aim of this study was to estimate the fertility and pregnancy outcomes after successful conservative treatment for placenta accreta.
Perrotin, Franck, Sentilhes, Loïc, M. Dreyfus, Benachi, Alexandra, Mahieu-Caputo, Dominique, Kayem, Gilles, Bauville, Estelle, Goffinet, François, E. Bauville, L. Marpeau, Pierre, Fabrice, D. Mahieu-Caputo, H. Fernandez, P. Descamps, Provansal, Magali, M. Provansal, F. Pierre, C. Ambroselli, Dreyfus, Michel, Fernandez, Hervé, F. Perrotin, G. Kayem, Bretelle, Florence, Marpeau, Loïc, Ambroselli, Clémence, Winer, Norbert, N. Winer, F. Goffinet, Descamps, Philippe, A. Benachi, L. Sentilhes, F. Bretelle   +31 more
core   +1 more source

Severe maternal and neonatal morbidity or mortality in forceps versus cesarean birth in the second stage of labor: A systematic review and meta‐analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Approximately one in four first‐time mothers reach the second stage of labor but cannot have a spontaneous vaginal birth, necessitating an intervention such as forceps to facilitate birth. Objective This study synthesizes evidence comparing severe maternal morbidity (SMM) and neonatal morbidity or mortality (SNMM) following forceps ...
Irina I. Oltean, Abirami Kirubarajan, Giulia M. Muraca   +2 more
wiley   +1 more source

Impact of Cell Saver technology on pro‐hemostatic factors transfusion in placenta accreta spectrum interventions: A 10‐year retrospective single‐center study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background While Cell Saver technology effectively reduces red blood cell transfusion in the perioperative setting, its impact on the need for pro‐hemostatic factors remains unclear. The use of Cell Saver could impact the requirements of pro‐hemostatic factors.
Ilan Levy, Maud Vachette, Emma Van Der Putten, Marine Chouteau, François Goffinet, Catherine Fischer, Aude Girault, Yoann Athiel   +7 more
wiley   +1 more source

Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder [version 4; peer review: 2 approved]

F1000Research, 2022
Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta  is increasingly seen today as the rate of cesarean section increases, however, the exact ...
Bancin Berry Eka Parda, Sarma Lumbanraja, M Rizki Yaznil, Andre M Siahaan   +3 more
doaj   +1 more source

The role of large language models as screening assistants in the diagnosis of placenta accreta spectrum pathologies

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Large language models (LLMs) are increasingly utilized in modern medicine. In obstetrics, their ability to interpret complex imaging, such as ultrasound images for placenta accreta spectrum (PAS), remains largely unexplored. This study aimed to investigate the capacity of multimodal LLMs to interpret sonographic images of placentae ...
Iason Psilopatis, Heidrun Schoenberger, Annkatrin Butenschoen, Thabea K. Musik, Georgia Levidou, Beatrice Mosimann, Gwendolin Manegold‐Brauer   +6 more
wiley   +1 more source

Ectopic Pregnancy after Conservative Management of Placenta Accreta: A Case Report

Taiwanese Journal of Obstetrics & Gynecology, 2004
Objective: Placenta accreta can be managed with preservation of the uterus, especially when further fertility is intended. We report a case of placenta accreta diagnosed intraoperatively and treated conservatively that was followed by an ectopic ...
Chun-Kuang Yang, Hsiao-Lin Hwa, Jin-Chung Shih, Fon-Jou Hsieh   +3 more
doaj   +1 more source

Cesarean delivery on maternal request: Trends, predictors, and short‐term outcomes using propensity score analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study determines short‐term maternal and neonatal outcomes associated with cesarean delivery on maternal request (CDMR) compared with planned vaginal delivery. Methods This retrospective cohort study included singleton pregnancies at term (37 + 0 to 41 + 6 weeks) delivered at a single tertiary medical center between January 2013
Ayelet Dangot, Danna Englender, Liat Zakar, Anat Lavie, Yariv Yogev, Omri Dominsky   +5 more
wiley   +1 more source

Placenta Accreta

مجلة كلية الطب, 2007
Placenta accrete is defined as an abnormally adherent placenta that is directly attached to the myometrium because of inadequate development of the fibrinoid layer (Nitabuch layer) and absence of decidua basilis either partially or totally.
Zahida Al-Saadi
doaj  

Timing of cesarean section in women with risk factors for placenta accreta spectrum disorder and maternal outcomes: A descriptive study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study reports maternal outcomes in women with risk factors for placenta accreta spectrum disorder (PAS) with cesarean section on the scheduled date and before in a setting where the intention was to wait at least until 36 weeks of gestation.
Lisanne R. Bonsen, Valerie Harskamp, Thomas van den Akker, Johanna G. van der Bom, Dacia D. C. A. Henriquez   +4 more
wiley   +1 more source

Role of scaling combination of risk factors in clinical and imaging findings during pregnancy in predicting placenta accreta spectrum

Caspian Journal of Internal Medicine, 2022
Background: Placenta accreta is one of the known causes of maternal mortality and morbidity. If diagnosed before delivery, appropriate actions can be taken.
Afsaneh Mohammadi, Zinatossadat Bouzari, karimollah Hajian-Tilaki, Mehrdad Nabahati, Raheleh Mehraeen   +4 more
doaj